Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
101,022,142
-
Share change
-
+921,198
-
Total reported value
-
$3,614,302,018
-
Put/Call ratio
-
47%
-
Price per share
-
$35.77
-
Number of holders
-
209
-
Value change
-
+$47,900,364
-
Number of buys
-
99
-
Number of sells
-
111
Institutional Holders of NPS PHARMACEUTICALS INC - COM (P103PS) as of Q4 2014
As of 31 Dec 2014,
NPS PHARMACEUTICALS INC - COM (P103PS) was held by
209 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,022,142 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, BlackRock Fund Advisors, ORBIMED ADVISORS LLC, BlackRock Institutional Trust Company, N.A., State Street Corp, and Invesco Ltd..
This page lists
209
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.